DD270909A5 - Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten - Google Patents

Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten Download PDF

Info

Publication number
DD270909A5
DD270909A5 DD88312142A DD31214288A DD270909A5 DD 270909 A5 DD270909 A5 DD 270909A5 DD 88312142 A DD88312142 A DD 88312142A DD 31214288 A DD31214288 A DD 31214288A DD 270909 A5 DD270909 A5 DD 270909A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
phenyl
formula
halogen
compounds
Prior art date
Application number
DD88312142A
Other languages
German (de)
English (en)
Inventor
Jan W F Wasley
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD270909A5 publication Critical patent/DD270909A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD88312142A 1987-01-12 1988-01-08 Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten DD270909A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/002,074 US4803197A (en) 1987-01-12 1987-01-12 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
DD270909A5 true DD270909A5 (de) 1989-08-16

Family

ID=21699148

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88312142A DD270909A5 (de) 1987-01-12 1988-01-08 Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten

Country Status (15)

Country Link
US (1) US4803197A (da)
EP (1) EP0276194A1 (da)
JP (1) JPS63174980A (da)
KR (1) KR880009002A (da)
AU (1) AU1016288A (da)
DD (1) DD270909A5 (da)
DK (1) DK9588A (da)
FI (1) FI880081A (da)
HU (1) HU198917B (da)
IL (1) IL85037A0 (da)
NO (1) NO880088L (da)
NZ (1) NZ223138A (da)
PH (1) PH23637A (da)
PT (1) PT86519B (da)
ZA (1) ZA88145B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2046941B1 (es) * 1991-10-24 1994-08-16 Consejo Superior Investigacion Procedimiento de obtencion de trioxo-pirazolo, (2,1) benzotiazepinas>
ES2040629B1 (es) * 1991-12-18 1994-06-16 Consejo Superior Investigacion Procedimiento de obtencion de derivados triciclicos de la benzotiazepina farmacologicamente activos.
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962261A (en) * 1974-02-04 1976-06-08 Warner-Lambert Company 2,3,4,5-tetra hydro-5-oxo-1-benzothiepi n-4-carboxamide 1,1-dioxides
SE420725B (sv) * 1974-09-26 1981-10-26 Ciba Geigy Ag Sett att framstella 2,3-dihydro-1-benstiepin-4-karboxylsyraamider
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4582850A (en) * 1985-02-28 1986-04-15 Ciba-Geigy Corporation Topical and systemic treatment of psoriasis using 7-chloro-N-(3,4-dichlorophenyl)-2,3-dihydro-5-hydroxy-1-benzothiepin-4-carboxamide 1,1-dioxide and pharmaceutically acceptable salts thereof
US4605665A (en) * 1985-02-28 1986-08-12 Ciba-Geigy Corporation Systemic treatment of splanchnic ischemia shock using 7-chloro-N-(3,4-dichlorophenyl)-2,3-dihydro-5-hydroxy-1-benzothiepin-4-carboxamide 1,1-dioxide and pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
HUT47262A (en) 1989-02-28
JPS63174980A (ja) 1988-07-19
DK9588D0 (da) 1988-01-11
NZ223138A (en) 1990-02-26
PT86519B (pt) 1991-12-31
FI880081A (fi) 1988-07-13
NO880088L (no) 1988-07-13
EP0276194A1 (de) 1988-07-27
NO880088D0 (no) 1988-01-11
PH23637A (en) 1989-09-27
DK9588A (da) 1988-07-13
HU198917B (en) 1989-12-28
PT86519A (en) 1988-02-01
KR880009002A (ko) 1988-09-13
ZA88145B (en) 1988-07-12
IL85037A0 (en) 1988-06-30
US4803197A (en) 1989-02-07
AU1016288A (en) 1988-07-14
FI880081A0 (fi) 1988-01-08

Similar Documents

Publication Publication Date Title
DE69805769T2 (de) Entzündungshemmende verbindungen
DE69222352T2 (de) N-(Aminoalkyl)piperidin-Verbindungen und ihre Enantiomere als Neurokinine-Receptoren Antagonisten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69130597T2 (de) Arylalkylamine, Verfahren zur Herstellung und diese enthaltende Arzneimittel
DE69905738T2 (de) Amidinderivate, ihre herstellung, ihre verwendung in medikamenten und sie enthaltende pharmazeutische zubereitungen
DE2705446C2 (da)
DE60015296T2 (de) Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten
DE602005005456T2 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
DE69118388T2 (de) Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
DE19955794A1 (de) Pyrrolidin-Derivate-CCR-3-Rezeptor-Antagonisten
WO1995013266A1 (de) Acylpyrrolalkansäuren und indol-2-alkansäuren sowie ihre derivate als hemmstoffe der phospholipase a¿2?
DE69730837T2 (de) Indolderivate zur behandlung von osteoporose
EP0287890A1 (de) Substituierte Pyrrole
WO2001070687A1 (de) Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können
DE2329430A1 (de) 1-acyl-3-(amino-niedrig-alkyl)-indole
DE3739882A1 (de) Substituierte hydroxylamine
EP0033156A2 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE69408674T2 (de) Phenylpyrrol-derivate und ihre verwendung als dopamin d3 antagonisten
EP0200947B1 (de) 1,3-Disubstituierte Imidazoliumsalze
DD291551A5 (de) Verfahren zur herstellung von substituierten hydroxamsaeurederivaten
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
EP0389425B1 (de) Neue Benzothiopyranylamine
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0171645A1 (de) Neue 2H-1-Benzopyran-2-on-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE69110217T2 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
DD270909A5 (de) Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten